DK3148541T3 - Thiazolidinoner som cellulære anandamidoptagelseshæmmere og anvendelse deraf i behandling af psykiatriske eller neurologiske forstyrrelser og inflammation, navnlig neuroinflammation - Google Patents
Thiazolidinoner som cellulære anandamidoptagelseshæmmere og anvendelse deraf i behandling af psykiatriske eller neurologiske forstyrrelser og inflammation, navnlig neuroinflammation Download PDFInfo
- Publication number
- DK3148541T3 DK3148541T3 DK15725041.6T DK15725041T DK3148541T3 DK 3148541 T3 DK3148541 T3 DK 3148541T3 DK 15725041 T DK15725041 T DK 15725041T DK 3148541 T3 DK3148541 T3 DK 3148541T3
- Authority
- DK
- Denmark
- Prior art keywords
- inflammation
- thiazolidinons
- anandamid
- neuro
- psychiatric
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title 1
- 208000012902 Nervous system disease Diseases 0.000 title 1
- 208000036110 Neuroinflammatory disease Diseases 0.000 title 1
- 208000025966 Neurological disease Diseases 0.000 title 1
- 230000001413 cellular effect Effects 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000003959 neuroinflammation Effects 0.000 title 1
- 208000020016 psychiatric disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14170448 | 2014-05-28 | ||
| EP14171022.8A EP2952188A1 (en) | 2014-06-03 | 2014-06-03 | Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation |
| PCT/EP2015/061914 WO2015181336A1 (en) | 2014-05-28 | 2015-05-28 | Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3148541T3 true DK3148541T3 (da) | 2020-12-07 |
Family
ID=54698144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15725041.6T DK3148541T3 (da) | 2014-05-28 | 2015-05-28 | Thiazolidinoner som cellulære anandamidoptagelseshæmmere og anvendelse deraf i behandling af psykiatriske eller neurologiske forstyrrelser og inflammation, navnlig neuroinflammation |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10300048B2 (da) |
| EP (1) | EP3148541B1 (da) |
| DK (1) | DK3148541T3 (da) |
| ES (1) | ES2845636T3 (da) |
| WO (1) | WO2015181336A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190352297A1 (en) * | 2017-01-06 | 2019-11-21 | Universitat Bern | Selective aurora a kinase inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE43728E1 (en) * | 2003-11-21 | 2012-10-09 | Actelion Pharmaceuticals Ltd. | Thiazolidin-4-one derivatives |
| MX2007001539A (es) | 2004-08-10 | 2007-04-23 | Exelisis Inc | Compuestos heterociclicos como agentes farmaceuticos. |
| WO2007059195A1 (en) * | 2005-11-14 | 2007-05-24 | University Of Southern California | Integrin-binding small molecules |
| CN101274918A (zh) | 2007-03-30 | 2008-10-01 | 中国科学院上海药物研究所 | 一类取代五元杂环化合物,其制备方法和医学用途 |
| WO2009109998A1 (en) * | 2008-03-03 | 2009-09-11 | Lupin Limited | Novel protein tyrosine phosphatase - ib inhibitors |
| CN101565408A (zh) | 2008-04-25 | 2009-10-28 | 国家新药筛选中心 | 一类受体信号转导增效剂,其制备方法和用途 |
| WO2010136221A1 (en) | 2009-05-29 | 2010-12-02 | Dr. August Wolff Gmbh & Co. Kg Arzneimittel | Dodeca-2e,4e-diene amides and their use as medicaments and cosmetics |
| WO2012170839A2 (en) * | 2011-06-09 | 2012-12-13 | Cardeus Pharmaceuticals, Inc. | Treatment of neuroinflammatory disease with selective cox1 inhibitors |
| PL3148990T3 (pl) * | 2014-05-28 | 2022-05-30 | Universität Bern | Związki tiazolidynonu i ich zastosowanie w leczeniu zaburzeń psychiatrycznych neurologicznych i stanów zapalnych, w szczególności stanów zapalnych układu nerwowego |
-
2015
- 2015-05-28 EP EP15725041.6A patent/EP3148541B1/en active Active
- 2015-05-28 US US15/314,105 patent/US10300048B2/en active Active
- 2015-05-28 ES ES15725041T patent/ES2845636T3/es active Active
- 2015-05-28 WO PCT/EP2015/061914 patent/WO2015181336A1/en not_active Ceased
- 2015-05-28 DK DK15725041.6T patent/DK3148541T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3148541B1 (en) | 2020-09-02 |
| US20170296515A1 (en) | 2017-10-19 |
| US10300048B2 (en) | 2019-05-28 |
| ES2845636T3 (es) | 2021-07-27 |
| WO2015181336A1 (en) | 2015-12-03 |
| EP3148541A1 (en) | 2017-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2023013I1 (no) | Combination of foslevodopa and foscarbidopa, each in all forms protected by the basic patent | |
| LT3472153T (lt) | Pirimidin-2-ilamino-1h-pirazolai kaip lrrk2 inhibitoriai, skirti naudoti neurodegeneracinių sutrikimų gydyme | |
| IL259441A (en) | Materials and methods for treatment of titin-based myopathies and other titinopaties | |
| DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
| DK3325509T3 (da) | Anti-tfr antistoffer og deres anvendelse i behandling af proliferative og inflammatoriske lidelser | |
| SI3331915T1 (sl) | Zaviralci kontrolnih točk za uporabo v zdravljenju rakov, ki se prenašajo s krvjo | |
| DK3119397T3 (da) | Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser | |
| DK3206715T3 (da) | Anvendelse af cannabidiol i behandling af tuberøs sklerosekompleks | |
| DK3185876T3 (da) | Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser | |
| DK3557998T3 (da) | Sammensætninger, kompositioner og anvendelsesmetoder | |
| PT3185957T (pt) | Patisiran para utilização no tratamento de amoloidose mediada por transtirretina | |
| DK3504187T3 (da) | Anvendelse af pridopidin til behandling af funktionel tilbagegang | |
| DK3215511T3 (da) | Substituerede pyrazolo(1,5-a)pyrimidiner og deres anvendelse i behandlingen af medicinske lidelser | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| PL3503890T3 (pl) | Stosowanie pridopidyny w leczeniu dystonii | |
| DK3307296T3 (da) | Timp2 til anvendelse til behandling af aldringsassocierede tilstande | |
| EP3334429C0 (en) | HYPERPHENYLALANINEMIA AND TREATMENTS THEREFOR | |
| DK3189074T3 (da) | Sammensætninger og metoder til behandling og forebyggelse af inflammation | |
| DK3362449T3 (da) | Sibirilin-derivater til anvendelse til at forebygge og/eller behandle lidelser associeret med cellulær nekroptose | |
| DK3164123T3 (da) | Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier | |
| DK3710000T3 (da) | Tradipitant til anvendelse til behandling af gastroparese | |
| DK3236960T3 (da) | Fluralaner til anvendelse i behandling af demodicose | |
| DK3374497T3 (da) | Modificerede makrofager til anvendelse i behandlingen af kræft | |
| IL251904A0 (en) | Apilimod for use in the treatment of melanoma | |
| DK3576738T3 (da) | Gaboxadolmonohydrat i behandling af tinnitus |